Aberdeen Group
MOH icon

Aberdeen Group’s Molina Healthcare MOH Stock Holding History

Aberdeen Group’s Portfolio MOH Stock Details MOH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.5M Sell
111,331
-3,853
-3% -$698K 0.04% 379
2026
Q1 		$15.4M Sell
115,184
-79,880
-41% -$12.7M 0.02% 491
2025
Q4 		$33.9M Buy
195,064
+59,498
+44% +$9.78M 0.05% 291
2025
Q3 		$26.2M Buy
135,566
+70,840
+109% +$13M 0.04% 353
2025
Q2 		$19.3M Sell
64,726
-10,400
-14% -$3.27M 0.03% 419
2025
Q1 		$24.5M Buy
75,126
+16,292
+28% +$4.92M 0.05% 338
2024
Q4 		$17.1M Sell
58,834
-2,427
-4% -$749K 0.03% 401
2024
Q3 		$21.1M Sell
61,261
-3,417
-5% -$1.13M 0.04% 376
2024
Q2 		$19.2M Sell
64,678
-22,474
-26% -$7.63M 0.04% 390
2024
Q1 		$35.8M Buy
87,152
+1,814
+2% +$703K 0.07% 260
2023
Q4 		$30.8M Buy
85,338
+69,202
+429% +$24.4M 0.07% 287
2023
Q3 		$5.29M Sell
16,136
-1,272
-7% -$400K 0.01% 549
2023
Q2 		$5.24M Buy
17,408
+2,118
+14% +$609K 0.01% 565
2023
Q1 		$4.09M Sell
15,290
-395
-3% -$114K 0.01% 607
2022
Q4 		$5.18M Buy
15,685
+26
+0.2% +$8.83K 0.01% 547
2022
Q3 		$5.17M Buy
15,659
+3,740
+31% +$1.2M 0.02% 546
2022
Q2 		$3.35M Sell
11,919
-90
-0.7% -$27.2K 0.01% 634
2022
Q1 		$4.09M Buy
12,009
+4,280
+55% +$1.32M 0.01% 626
2021
Q4 		$2.46M Sell
7,729
-437
-5% -$130K 0.01% 747
2021
Q3 		$2.29M Sell
8,166
-798
-9% -$211K 0.01% 766
2021
Q2 		$2.27M Sell
8,964
-111
-1% -$27.9K 0.01% 746
2021
Q1 		$2.12M Sell
9,075
-598
-6% -$133K ﹤0.01% 757
2020
Q4 		$2.06M Buy
9,673
+597
+7% +$123K 0.01% 740
2020
Q3 		$1.66M Sell
9,076
-1,838
-17% -$334K ﹤0.01% 735
2020
Q2 		$1.94M Buy
10,914
+3,524
+48% +$600K 0.01% 707
2020
Q1 		$1.03M Buy
7,390
+1,304
+21% +$175K ﹤0.01% 761
2019
Q4 		$826K Sell
6,086
-443
-7% -$55.8K ﹤0.01% 828
2019
Q3 		$716K Sell
6,529
-855
-12% -$111K ﹤0.01% 828
2019
Q2 		$1.05M Sell
7,384
-680
-8% -$93.1K ﹤0.01% 818
2019
Q1 		$1.15M Buy
+8,064
New +$1.09M ﹤0.01% 796

Other funds holding MOH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Aberdeen Group's MOH Position: Q2 2026 in Review

Aberdeen Group reduced its Molina Healthcare (MOH) stake by 3.3% in Q2 2026, selling an estimated $698K and leaving 111,331 shares worth $25.5M. The position accounts for 0.04% of the portfolio, ranked #379.

Aberdeen Group first reported a position in MOH in Q1 2019 and has held it in 30 quarters since. The position peaked at $35.8M in Q1 2024. 599 funds tracked by Wall St. Rank hold MOH as of Q2 2026.

  • Aberdeen Group held 111,331 shares of Molina Healthcare worth $25.5M as of Q2 2026.
  • Aberdeen Group sold 3,853 Molina Healthcare shares in Q2 2026, an estimated $698K.
  • Molina Healthcare made up 0.04% of Aberdeen Group's portfolio in Q2 2026, its #379 holding.
  • Aberdeen Group first reported a position in Molina Healthcare in Q1 2019 and has held it in 30 quarters since.
  • Aberdeen Group's Molina Healthcare position peaked at $35.8M in Q1 2024.
  • 599 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.